J Korean Ophthalmol Soc > Volume 53(2); 2012 > Article
Journal of the Korean Ophthalmological Society 2012;53(2):342-347.
DOI: https://doi.org/10.3341/jkos.2012.53.2.342    Published online February 15, 2012.
Moxifloxacin Mixed Augmented Amniotic Membrane Transplantation for Perforating Infectious Keratitis.
Hong Kyun Kim
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea. okeye@knu.ac.kr
천공된 세균성 각막염에서 목시플록사신 함유 강화양막이식술의 임상적 적용 2예
김홍균
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea
Abstract
PURPOSE
To report the clinical results of moxifloxacin mixed augmented amniotic membrane transplantation (AMT) in 2 patients with perforating infectious keratitis. CASE SUMMARY: Moxifloxacin mixed augmented amniotic membrane transplantations were performed in 2 patients with rapidly deteriorating deep perforated bacterial keratitis. All patients preserved their eyesight. Complete re-epithelization over the amniotic membrane were observed within a month. The corneal surfaces were healed with opacity, and there were no active infectious infiltrations or recurrences for 3 months after application. CONCLUSIONS: Moxifloxacin mixed augmented AMT has proven to be successful both tectonically and physiologically for cases with perforating active bacterial keratitis.
Key Words: Amniotic membrane;Corneal perforation;Corneal ulcer;Fibrin glue;Moxifloxacin


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2021 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next